Vaccines and global health: In search of a sustainable model for vaccine development and delivery.
Rino RappuoliSteven BlackDavid E BloomPublished in: Science translational medicine (2020)
Most vaccines for diseases in low- and middle-income countries fail to be developed because of weak or absent market incentives. Conquering diseases such as tuberculosis, HIV, malaria, and Ebola, as well as illnesses caused by multidrug-resistant pathogens, requires considerable investment and a new sustainable model of vaccine development involving close collaborations between public and private sectors.
Keyphrases
- global health
- multidrug resistant
- healthcare
- gram negative
- hiv testing
- health insurance
- hiv aids
- public health
- hiv infected
- antiretroviral therapy
- hiv positive
- mycobacterium tuberculosis
- human immunodeficiency virus
- men who have sex with men
- mental health
- drug resistant
- acinetobacter baumannii
- smoking cessation
- south africa
- antimicrobial resistance
- pulmonary tuberculosis
- cystic fibrosis
- pseudomonas aeruginosa